Fig 1.
Flowchart depicting the enrollment process of patients diagnosed with Pseudomonas aeruginosa infection and the subsequent data analysis.
Table 1.
Empirical antibiotic therapy received (N = 477).
Table 2.
Definitive antibiotic therapy administered (N = 463)a.
Fig 2.
The Kaplan-Meier survival curve for patients infected with Pseudomonas aeruginosa.
Fig 3.
The Kaplan-Meier survival curves for patients with Pseudomonas aeruginosa infection based on the appropriateness of the initial antibiotic therapy received.
Table 3.
Comparison of survival time between patients who died after receiving appropriate antibiotic therapy and those who died after receiving inappropriate antibiotic therapy (N = 69 out of 465).
Fig 4.
The Kaplan-Meier survival curves for patients with difficult-to-treat resistant (DTR) and non-DTR Pseudomonas aeruginosa infection.
Table 4.
Comparison of survival times between patients infected with difficult-to-treat resistant and non-difficult-to-treat Pseudomonas aeruginosa isolates (N = 69 out of 465).
Table 5.
Univariate analysis of predictors associated with mortality in patients with Pseudomonas aeruginosa infection (N = 465)a.
Table 6.
Logistic regression analysisa of the significant predictors associated with mortality in patients with Pseudomonas aeruginosa infection.